Patents by Inventor Ian Richard Mathews

Ian Richard Mathews has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immuno inhibitory heterocyclic compounds
    Patent number: 7566713
    Abstract: Compounds of formula (I) are CD80 inhibitors, and of value for immunomodulation, e.g. in rheumatoid arthritis, multiple sclerosis, diabetes, asthma, transplantation, systemic lupus erythematosis and psoriasis: wherein Y is —CH2—, —CH2CH2—, or CH2CH2CH2—; R1 represents H; F; methyl, trifuoromethyl, methoxy or triflioromethoxy; R3 represents H; F; CI; Br; NO2; CN; C1C6 alkyl optionally substituted by F or Cl; or C1-C6 alkoxy optionally substituted by F; R4 represents a carboxylic acid group (—COOH) or an ester thereof, or —C(?O) NR6R7—NR7C(?O)R6, NR7C(?O)OR6, NHC(?O) or NHC(?S)NR7R6 wherein R6 and R7 are as defined in the specification and X represents a bond or a divalent radical as defined in the specification.
    Type: Grant
    Filed: April 26, 2005
    Date of Patent: July 28, 2009
    Assignee: Medigene Limited
    Inventor: Ian Richard Mathews